EXHIBIT 10.2
PREFERRED STOCK PURCHASE AGREEMENT
This Preferred Stock Purchase Agreement (the "Agreement") is made and
entered into as of the 1st day of March, 2000, by and between AVIATION GROUP,
INC., a Texas corporation (the "Company"), and XXXXXXXXXX.XXX, LTD. (the
"Investor").
1. AUTHORIZATION AND SALE OF THE SHARES; OTHER AGREEMENTS.
1.1 Authorization of the Shares. The Company shall, as of the
Closing (as defined below), adopt and file with the Secretary of State of the
State of Texas, the Certificate of Designation (the "Certificate"),
substantially in the form attached hereto as Exhibit A so as to establish and
designate 1,500 shares of Series B Preferred Stock (the "Series B Stock") having
the rights, restrictions, privileges, redemption rights and preferences, as set
forth in the Certificate.
1.2 Sale of the Shares. Subject to the terms and conditions
hereof, the Investor agrees to purchase at the Initial Closing (as defined
below), and the Company agrees to sell and issue to the Investor at the Initial
Closing, 200 shares of the Series B Stock for an aggregate purchase price of
U.S. $2,000,000. The purchase price represents $10,000 per share (the "Per Share
Price").
1.3 Additional Sales of Shares. Subject to the terms and
conditions hereof, the Investor agrees to purchase at one or more Subsequent
Closings (as defined below), and the Company agrees to sell and issue to the
Investor at such Subsequent Closings, additional shares of the Series B Stock at
a purchase price per share equal to the Per Share Price. Such purchases shall
occur from time to time when the Investor and the Company mutually agree that
additional funds are needed by Global Leisure Travel, Inc., a Washington
corporation ("Global"), to pay its matured indebtedness or to fund its
operations. The maximum aggregate purchase price payable by the Investor for all
Series B Stock purchased under this Agreement shall in no event exceed
$10,500,000.
1.4 Global Leisure Agreement.
(a) In connection with this Agreement, the Company is entering
into a Preferred Stock Purchase Agreement (the "Global Agreement") with Global,
pursuant to which the Company is purchasing shares of Global's Series B
Preferred Stock (the "Global Stock"). Global is in need of funds to finance
repayment of matured debt and for working capital purposes. It is the intent of
the parties to this Agreement that the proceeds of the sale of the Series B
Stock will be used to purchase the Global Stock except to the extent of U.S.
$500,000 to be used by the Company as contemplated in Section 5.1 of this
Agreement. The initial consummation of the Global Agreement is conditioned on,
and will occur simultaneously with, the Initial Closing under this Agreement.
1
(b) The Global Stock will represent a control voting equity
position in Global so that the Company will be able to elect all of the Board of
Directors of Global. The Company and the Investor agree that the directors of
Global shall be Xxxxxxx Xxxxxx, Xxxx Xxxxx and Xxx Xxxxxx, and the Company
agrees to vote or execute consents with respect to its Global Stock to so elect
such directors from time to time. The Company also agrees to vote and execute
written consents with respect to the Global Stock only with the prior approval
of the Investor, which shall not be unreasonably withheld or delayed. Any such
action shall be consistent with the goal of the parties to effect a business
combination of the operations and businesses of the Company, the Investor and
Global.
(c) If any cash dividends are received by the Company on the
Global Stock, the Company agrees, to the extent permitted by applicable law, to
cause such dividends to be promptly passed through and declared as a dividend on
the Series B Stock so that the Investor will receive its pro rata share of same.
1.5 Planned Mergers.
(a) The Company and the Investor understand and agree that
this Agreement is the first step in the acquisition by the Company of 100% of
the equity ownership in the Investor and the Investor's shareholders obtaining
control of the Company. The parties hereto are in the process of negotiating an
Agreement and Plan of Merger (the "Merger Agreement") pursuant to which a
wholly-owned, Canadian subsidiary of the Company will merge with and into the
Investor (the "Merger"). Reference is made to that certain letter of intent
dated February 25, 2000 from the Investor to the Company (the "Letter of
Intent") for a summary of the intentions of the parties with respect to the
Merger. Subject to and in accordance with the Letter of Intent, the Company and
the Investor agree to negotiate in good faith the terms of the Merger Agreement
and to use reasonable efforts to execute the Merger Agreement as soon as
practicable but in no event later than March 25, 2000.
(b) The consummation of the Merger will be conditioned on (i)
the prior merger of a wholly-owned subsidiary of the Company with and into
Global (the "Global Merger") and (ii) the exchange of the then outstanding
corporate indebtedness of Global (the "Debt Exchange") by the holders thereof
for the issuance by the Company to the holders of such indebtedness of (a)
shares of the Company's Series A Convertible Preferred Stock (the "Series A
Preferred Stock") with an initial aggregate liquidation preference equal to the
principal amount of such indebtedness (the "Principal Amount") and (b) warrants
(the "Exchange Warrants") to purchase 750,000 shares of the Company's Common
Stock. Pursuant to the terms of the Global Merger, the Company will issue to the
holders of all of Global's outstanding common stock and rights to purchase
Global common stock in full cancellation of such common stock and rights,
warrants (the "Equity Warrants") to purchase 3.5 million shares of the Company's
Common Stock. The terms of the Equity Warrants and the Exchange Warrants are set
forth in more detail on Exhibit B attached hereto. The terms of the Series A
Preferred Stock are set forth in more detail on Exhibit C attached hereto. The
Company and the Investor agree to cooperate to facilitate the negotiation,
execution and consummation of appropriate merger and exchange agreements between
Global, the Company and the holders of Global's indebtedness so that the
2
Global Merger and the Debt Exchange can be consummated as soon as practicable
but no later than March 10, 2000.
1.6 Bridge Financing.
(a) Subject to the execution of definitive subscription
documents reasonably acceptable to Investor, Xxxxxx Capital Management ("DCM"),
together with other broker/dealers selected by DCM with the concurrence of the
Investor and the Company in compliance with applicable securities laws, will be
using its commercially reasonable best efforts to sell up to U.S. $15,000,000 of
Series B Stock and U.S. $3,000,000 of Common Stock to further finance the
Merger, the Global Merger, Global's operations and the Company. To the extent
the amount of new cash proceeds from such Bridge Financing exceeds the aggregate
liquidation preference of shares of Series B Stock held by the Investor, such
excess will be used by the Company to redeem outstanding Series B Stock from the
Investor for a redemption price equal to the Per Share Price. The Company and
the Investor agree to effect such redemption with such excess proceeds. Except
as set forth in immediately preceding sentence, the Bridge Financing may also be
effected by the transfer by the holders of existing indebtedness of Global of
such indebtedness to the Company, in which case any guarantees of such
indebtedness shall be released by the Company. The purchasers of the Series B
Stock in the Bridge Financing, whether by cash or by transfer of existing
indebtedness of Global, shall be issued by the Company warrants (the "Bridge
Warrants") to purchase 750,000 shares of Common Stock for each U.S. $100,000 in
liquidation preference of the Series B Stock. The Bridge Warrants will be
transferable only with the Series B Stock prior to closing of the Merger.
(b) Subject to and solely upon the consummation of at least
U.S. $7,500,000 in new cash proceeds from the Bridge Financing to be arranged by
DCM, the proceeds of such financing will be used by the Company to purchase
additional shares of Global Stock under the Global Agreement. The proceeds of
such sale shall be used by Global to repay the remaining institutional
indebtedness of Global due March 31, 2000 in the approximate amount of U.S.
$7,500,000 as more particularly described on Schedule 1.6. In the event
insufficient proceeds of the Bridge Financing are raised, it is expected that
Global will cause the remaining portion of such U.S. $7,500,000 of institutional
indebtedness to be transferred to the Company in exchange for issuance by the
Company of additional Series B Stock and Bridge Warrants, in which case any
guarantees of such indebtedness shall be released by the Company.
1.7 Exchange Offer.
(a) After execution of the Merger Agreement, the Company will
use commercially reasonably efforts to file and cause to become effective a
registration statement with respect to a registered offer (the "Exchange Offer")
to the holders of the Series B Stock to exchange such outstanding shares of
Series B Stock for an issue of the Company's Series C Preferred Stock (the
"Exchange Stock") having terms identical to the Series A Preferred Stock,
including the ability of the Company to cause the conversion thereof into Common
Stock, except that the conversion price of the Exchange Stock shall be U.S.
$3.00 per share and the Exchange Stock shall be mandatorily redeemable by the
Company on February 28, 2001 at a price per share equal to the liquidation
preference thereof, which will include accrued but unpaid
3
dividends. The Company's obligation to file and cause to become effective such
registration statement for the Exchange Offer is conditioned upon the prior
execution by the Company and the Investor of the Merger Agreement. The
consummation of the Exchange Offer will be conditioned upon the consummation of
the Merger.
(b) Upon such registration statement being declared effective,
the Company will offer the Exchange Stock, subject to consummation of the
Merger, in return for surrender of the Series B Stock. Such offer shall remain
open for not less than 20 business days after the date notice of the Exchange
Offer is mailed to the holders of the Series B Stock. For each share of Series B
Stock surrendered to the Company under the Exchange Offer, the holder of such
share will receive a share of Exchange Stock of equal liquidation preference.
Cumulative dividends on each share of Exchange Stock shall accrue from the date
immediately following the last date on which dividends were paid on the share of
Series B Stock so surrendered or, if no dividends have even been paid on the
Series B Stock, from the date of original issuance of the share of the Series B
Stock. If the Company effects the Exchange Offer, the Company will be entitled
to close the Exchange Offer contemporaneously with the consummation of the
Merger; provided, however, the Company must accept all Series B Stock
theretofore validly tendered in accordance with the Exchange Offer.
1.8 Limitation on Liquidation Preference. The parties acknowledge
that Global has failed to deliver to the Company all of the disclosure schedules
required by the Global Agreement but has promised to deliver all of such
schedules to the Company within five (5) business days after the date hereof.
Notwithstanding anything in this Agreement or the Certificate to the contrary,
upon any liquidation, dissolution or winding up of the Company, whether
voluntary or involuntary, the Investor agrees that the aggregate liquidation
preference of the Series B Stock held by the Investor shall be limited to and
payable solely from the total net cash amount realized by the Company through
the Company's Global Stock either from the liquidation of Global by the Company
or from the liquidation of the Company's Global Stock. This Section 1.8 will
terminate if and when the disclosure schedules are delivered by Global to the
Company in a form deemed satisfactory to the Company in its sole discretion.
2. CLOSINGS; DELIVERIES.
2.1 Closings. The initial closing (the "Initial Closing") of the
purchase and sale of the Series B Stock hereunder shall be held at the offices
of Jenkens & Xxxxxxxxx, a Professional Corporation, 0000 Xxxx Xxxxxx, Xxxxx
0000, Xxxxxx, Xxxxx 00000, on March 1, 2000 or such other time and place as
agreed to by the Company and the Investor (the date of the Initial Closing is
hereinafter referred to as the "Initial Closing Date"). Each subsequent closing
("Subsequent Closing") of the purchase and sale of additional shares of the
Series B Stock shall be held at such time as agreed to by the Company and the
Investor at the offices of Jenkens & Xxxxxxxxx, a Professional Corporation, or
at such other place as agreed to by the Company and the Investor (the date of
each Subsequent Closing is hereinafter referred to as a "Subsequent Closing
Date").
2.2 Series B Stock Certificate. At each of the Closings, the
Company will deliver to the Investor a legended certificate, registered in the
Investor's name, representing the Series B Stock to be purchased by the Investor
at the Closing upon payment by the Investor of the
4
purchase price therefor by federal wire transfer of immediately available funds
to an account designated by the Company.
2.3 Initial Closing Documents. At the Initial Closing, the Company
shall deliver, in addition to the stock certificate required by Section 2.2, the
following:
(i) the Certificate, in the form attached hereto as
Exhibit A, together with a Certificate from the Secretary of State of
Texas evidencing the filing thereof; and
(ii) a certificate dated as of the Closing Date by the
secretary or other officer of the Company certifying as to the
incumbency of the Company's officers and the authenticity of the
Certificate and Board of Director resolutions approving the
transactions contemplated hereby.
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby
represents and warrants to the Investors as follows:
3.1 Organization and Standing. The Company is a corporation duly
organized and existing under, and by virtue of, the laws of the State of Texas
and is in good standing under such laws. The Company is qualified to do business
as a foreign corporation in all jurisdictions where the nature of its business
requires it to be so qualified, except where the failure to be so qualified
would not have a material adverse effect on the Company. The Company has the
requisite corporate power to own and operate its properties and assets and to
carry on its business as presently conducted and as proposed to be conducted.
3.2 Corporate Power. The Company has all requisite legal and
corporate power (i) to execute and deliver this Agreement and the agreements
contemplated hereby; (ii) (when the Certificate has been adopted and filed), to
sell the Series B Stock; and (iii) to carry out and perform its other
obligations under the terms of this Agreement and the agreements contemplated
hereby.
3.3 Capitalization. The authorized capital of the Company
consists, or will consist immediately prior to the Closing of:
(a) Preferred Stock. 5,000,000 shares of Preferred Stock,
par value $0.01, of which 1,500 have been or prior to the Initial Closing will
be designated Series B Preferred Stock and none of which are isssued and
outstanding. The rights, privileges and preferences of the Series B Stock will
be as stated in the Certificate.
(b) Common Stock. 10,000,000 shares of common stock, par
value $0.01 ("Common Stock"), of which 3,573,929 shares are issued and
outstanding.
(c) The outstanding shares of Common Stock are all duly
authorized and validly issued, fully paid and nonassessable.
(d) Except as set forth on Schedule 3.3 hereto, there are
not outstanding any options, warrants, rights (including conversion or
preemptive rights) or agreements for the
5
purchase or acquisition from the Company of any shares of its capital stock.
Except as set forth on Schedule 3.3, the Company is not a party or subject to
any agreement or understanding, and, to the best of the Company's knowledge,
there is no agreement or understanding between any persons and/or entities,
which affects or relates to the voting or giving of written consents with
respect to any security or by a director of the Company.
3.4 Authorization. All corporate action on the part of the Company
and its directors and officers necessary for the authorization, execution,
delivery and performance of all obligations of the Company under this Agreement
and the agreements contemplated hereby has been (or will be) taken prior to the
Closing. This Agreement constitutes the valid and binding obligation of the
Company and is enforceable in accordance with its terms, except as
enforceability may be limited by bankruptcy, insolvency or other laws affecting
the enforcement of creditors' rights generally, and except that the availability
of the remedy of specific performance or other equitable relief is subject to
the discretion of the court before which any proceeding therefor may be brought.
3.5 Validity of Stock. The Series B Stock, when issued in
compliance with the provisions of this Agreement, will be validly issued, fully
paid and nonassessable, will be free of any liens or encumbrances, and shall not
be subject to any preemptive rights, rights of first refusal or redemption
rights, other than as provided herein or in the Certificate.
3.6 Compliance with Other Instruments; None Burdensome, etc. The
execution, delivery and performance of and compliance with this Agreement, and
the issuance of the Series B Stock will not result in any violation of any term
of (i) the Company's Articles of Incorporation or its Bylaws, (ii) any material
provision of any mortgage, indenture, contract, agreement or instrument to which
the Company is a party or by which it is bound, or (iii) any judgment, decree or
order binding upon the Company or any statute, rule or regulation applicable to
the Company which violation would have a material adverse effect on the Company.
3.7 Governmental Consents, etc. No consent, approval or
authorization of, or registration, declaration, designation, qualification or
filing with, any governmental authority on the part of the Company is required
in connection with the valid execution and delivery of this Agreement, the
offer, sale or issuance of the Series B Stock or the consummation of any other
transaction contemplated hereby, except for filings which have been made or will
be timely made, as appropriate.
3.8 Material Contracts. The Company has filed with the Securities
and Exchange Commission (the "Commission") all agreements, contracts, leases or
other documents of a character required by the rules and regulations of the
Commission to be filed by the Company as exhibits to any registration statement
or report filed by the Company (the "Material Contracts").
3.9 Financial Statements. The Company's Form 10-KSB Annual Report
for the year ended June 30, 1999, and Form 10-QSB Quarterly Reports for the
quarter ended December 31, 1999, as filed with the Commission, collectively
contain a true, correct and complete copy of (a) the consolidated audited
balance sheets, statements of operations and statements of cash
6
flow of the company for the fiscal year ended June 30, 1999 and (b) consolidated
unaudited balance sheets, statements of operations and statements of cash flow
of the Company for the six-month period ended December 31, 1999 (the "Financial
Statements"). The Financial Statements are in accordance with the books and
records of the Company, have been prepared consistently with past practices,
have been prepared in accordance with GAAP (except that the unaudited Financial
Statements do not contain notes required by GAAP) and present fairly in all
material respects the financial position of the Company on the dates of such
statements and the results of operations for the periods covered. The Company
maintains its books, records and accounts in accordance with good business
practice and in sufficient detail to reflect fairly and in all material respects
the transactions and dispositions of its assets, liabilities and securities.
3.10 Changes. Since December 31, 1999, there has not been any
material adverse change in the assets, liabilities, financial condition or
operating results of the Company from that reflected in the Financial
Statements, except changes in the ordinary course of business and except for the
sale by the Company of its subsidiary Casper Air Service.
3.11 Brokerage or Finder's Fees. The Company has not incurred any
obligation or liability for brokerage commissions, finder's fees or similar
compensation in connection with the transactions contemplated by this Agreement
based on any arrangement or agreement made by the Company.
3.12 Commission Reports. The Company has filed in a timely manner
with the Commission all forms, financial statements, documents and reports
(collectively the "Commission Reports") required to be filed by the Company
pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange
Act"). Such Commission Reports were prepared in all material respects in
accordance with the Exchange Act and do not contain any untrue statement of a
material fact or omit to state a material fact necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading.
4. INVESTOR'S REPRESENTATIONS. The Investor hereby represents and warrants
as follows:
4.1 Authorization. Such Investor has full power and authority to
enter into this Agreement and all other agreements, documents or instruments
contemplated by this Agreement and this Agreement constitutes its valid and
legally binding obligation, enforceable in accordance with its terms, except as
may be limited by (a) applicable bankruptcy, insolvency, reorganization or other
laws of general application relating to or affecting the enforcement of
creditors' rights generally and (b) the effect of rules of law governing the
availability of equitable remedies.
4.2 Purchase Entirely for Own Account. The Series B Stock to be
received by such Investor will be acquired for investment for such Investor's
own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and such Investor has no present intention of
selling, granting any participation in, or otherwise distributing the same.
7
4.3 Disclosure of Information. Such Investor has reviewed the
Company's public filings and has had an opportunity to ask questions and receive
answers from the Company regarding the Company, its financial condition and the
terms and conditions of the offering of the Series B Stock.
4.4 Investment Experience. Such Investor is an experienced
investor in securities and acknowledges that it is able to fend for itself, can
bear the economic risk of its investment and has such knowledge and experience
in financial or business matters that it is capable of evaluating the merits and
risks of the investment in the Series B Stock. Such Investor also represents it
is an "accredited investor" within the meaning of Rule 501(a) promulgated under
the Securities Act of 1933, as amended (the "Act").
4.5 Restricted Securities. Such Investor understands that the
shares of Series B Stock it is purchasing are characterized as "restricted
securities" under the federal securities laws inasmuch as they are being
acquired from the Company in a transaction not involving a public offering and
that under such laws and applicable regulations such securities may not be
resold without registration under the Act and applicable state securities laws,
except in certain limited circumstances. In this connection, such Investor
represents that it is familiar with Rule 144 under the Act, as presently in
effect, and understands the resale limitations imposed thereby and by the Act.
Such Investor agrees that in no event will it make a transfer or disposition of
any of the Series B Stock unless and until, if requested by the Company, it
shall have furnished to the Company (at the expense of the Investor or
transferee) an opinion of counsel or other evidence, reasonably satisfactory to
the Company, to the effect that such transfer may be made without restrictions
under the Act. Such Investor understands that the Company is under no obligation
to register any of the securities sold hereunder. Such Investor understands that
no public market now exists for the Series B Stock and that it is uncertain
whether a public market will ever exist for the Series B Stock.
4.6 Legends. It is understood that the certificates evidencing the
Company's Series B Stock shall bear the following legend, as well as any other
legend as may be required by applicable federal and state securities laws:
"THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF
ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE TRANSFERRED, RESOLD, PLEDGED OR OTHERWISE DISPOSED OF
EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS,
PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM."
4.7 Brokerage or Finder's Fees. Such Investor has not incurred any
obligation or liability for brokerage commissions, finder's fees or similar
compensation in connection with the transactions contemplated by this Agreement
based on any arrangement or agreement made by such Investor.
8
5. COVENANTS.
5.1 Use of Proceeds. The Company shall use all the proceeds from
the sale of the Series B Stock to purchase shares of Global Stock; provided,
however, that the Company may use up to U.S. $500,000 of such proceeds to pay
costs and expenses incurred by the Company in connection with this Agreement,
the Global Agreement, the Merger, the Global Merger, the other transactions
contemplated hereby, and related transactions, subject to the approval of the
Investor, and to pay the outstanding accounts payable owed by the Company to its
accountants and attorneys.
5.2 Management Changes. The Company agrees that its Board of
Directors shall promptly act to (i) elect Xxxx Xxxxx as President and Chief
Executive Officer of the Company and (ii) expand the Board of Directors of the
Company by two members and appoint Xxxx Xxxxx and another designee of Investor
as members of the Company's Board of Directors to fill such new vacancies.
6. MISCELLANEOUS.
6.1 Governing Law. This Agreement shall be governed by and
construed under the laws of the State of Texas, without regard to the State's
conflicts of law rules.
6.2 Survival. The representations and warranties of the parties
made herein shall survive the Closing for a period of six (6) months.
6.3 Successors and Assigns. Except as otherwise expressly provided
herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the permitted successors, assigns, heirs, executors and administrators of
the parties.
6.4 Entire Agreement; Amendment. This Agreement and the other
documents delivered pursuant hereto constitute the full and entire understanding
and agreement among the parties with regard to the subjects hereof and thereof.
This Agreement may be amended, waived, discharged or terminated only pursuant to
an affirmative vote or written consent of the holders of at least a majority of
the shares of the Series B Stock and the Company and such amendment or waiver
shall be binding upon all such holders.
6.5 Brokerage and Finder's Fees. The Company, on the one hand, and
the Investor, on the other hand, will be responsible for, and will indemnify and
hold harmless the other party for, any brokerage commissions, finder's fees or
similar compensation in connection with the transactions contemplated by this
Agreement based on any arrangement or agreement made by the Company, on the one
hand, or by the Investor, on the other hand.
6.6 Notices, etc. All notices and other communications required or
permitted hereunder shall be given in writing and shall be deemed effectively
given upon personal delivery or upon deposit with the United States Postal
Service, by certified mail, return receipt requested, postage prepaid, or
otherwise delivered by hand or by messenger, addressed (a) if to the Investor,
to xxxxxxxxxx.xxx, Ltd., 204-3237 King Xxxxxx Highway, South Surrey, British
Columbia, V4P
9
1B7, Canada, or to such other address as such Investor shall have furnished to
the Company in writing, or (b) if to the Company, at 000 Xxxxx Xxxxx Xxxxxx,
Xxxxx 0000, Xxxxxx, Xxxxx 00000, U.S.A., or at such other address as the Company
shall have furnished to the Investor in writing.
6.7 Expense of Transaction. Except as provided in SECTION 5.1 of
this Agreement, each party hereto shall bear its own expenses in connection with
the transactions described herein.
6.8 Titles and Subtitles. The titles of the Sections, paragraphs
and subparagraphs of this Agreement are for convenience of reference only and
are not to be considered in construing this Agreement.
6.9 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.
6.10 Timely Performance. Time is of the essence as to the
performance of the obligations required of the respective parties under this
Agreement.
6.11 Attorneys' Fees. If any action at law or in equity (including
arbitration) is necessary to enforce or interpret the terms of this Agreement,
the prevailing party shall be entitled to reasonable attorneys' fees, costs and
necessary disbursements in addition to any other relief to which such party may
be entitled.
6.12 Severability. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith. In the event that the parties cannot reach a
mutually agreeable and enforceable replacement for such provision, then (a) such
provision shall be excluded from this Agreement, (b) the balance of this
Agreement shall be interpreted as if such provision were so excluded and (c) the
balance of this Agreement shall be enforceable in accordance with its terms.
[The remainder of this page is intentionally left blank,
signature page follows.]
10
IN WITNESS WHEREOF, the Company and the Investor have executed and
delivered this Agreement as of the day and year first above written.
THE COMPANY:
AVIATION GROUP, INC.
By: /s/ Xxx X. Xxxxxxx
Xxx X. Xxxxxxx
President
INVESTOR:
XXXXXXXXXX.XXX, LTD.
By: /s/ Xxxx Xxxxx
Name: Xxxx Xxxxx
Title: CEO
11
EXHIBIT A
Form of Statement of Resolution Establishing Series of Shares
12
EXHIBIT B
Terms of Warrants
Series The Exchange Warrants and the Equity Warrants
(together, the "Warrants") shall be issued in
different series. The Exchange Warrants shall
be issued as Series A Warrants and the Equity
Warrants shall be designated as Series B
Warrants.
Term Each series shall have a term of two years
from the date the securities issuable upon
their exercise are freely tradable under the
Securities Act of 1933, as amended, and the
rules and regulations thereunder.
Exercise Price Series A: The Series A Warrants shall have an
exercise price of US$4.00 per share.
Series B: The Series B Warrants shall have an
exercise price of US$3.00 per share.
EXHIBIT C
Terms of SEries A Preferred Stock
Liquidation Preference The initial liquidation preference (the
"Series A Liquidation Preference") of the
Series A Preferred Stock shall be Principal
Amount. The Series A Liquidation Preference
shall be increased by any accrued but unpaid
dividends, which shall be prorated in the
event of any redemption or conversion.
Dividends Each holder of Series A Preferred Stock will
be entitled to receive cumulative monthly
dividends if and when declared by the board of
directors, at an annual rate equal to 9% (the
"Series A Dividend Rate") of the Series A
Liquidation Preference of the Series A
Preferred Stock held by such holder.
Conversion at the Option of The Series A Preferred Stock may be converted
the Surviving Corporation at the option of the Company into Company
Common Stock at any time after its issuance,
provided that there shall not have been
effected a common stock, preferred stock or
debt financing for the Company with gross cash
proceeds of at least US$25 million on terms
reasonably acceptable to the Company after or
in connection with the Merger. If the Company
elects to effect such a conversion, it shall
give notice thereof to the holders of the
Series A Preferred Stock (the date of delivery
of such notice the "Conversion Date") and the
Series A Preferred Stock shall automatically
be converted into a number of shares of the
Company's Common Stock equal to the quotient
obtained by dividing (i) the Series A
Liquidation Preference on the Conversion Date
by (ii) the arithmetic mean of closing bid
prices of the Company's Common Stock as
reported by Bloomberg, L.P. for the 21 trading
days preceding the Conversion Date (the
"Conversion Rate").
Rank The Series A Preferred Stock will rank junior
in rights to dividends and liquidation
preference to the Series B Stock (and the
Series C Preferred Stock for which the Series
B Stock may be exchanged).
Redemption The Series A Preferred Stock will be
redeemable at the option of the Investor at
any time on or prior to September 30, 2000 at
a price per share equal to the Series A
Liquidation Preference (the "Redemption
Price"). Notice of redemption shall be given
at least 30 days in advance, during which time
it may be converted at the holder's election.
Voting Rights After the earlier of September 30, 2000 or the
consummation of the Merger, the Series A
Preferred Stock shall vote on all matter
submitted to a vote of the holders of the
Company's Common Stock on an as-converted
basis. The Series A Preferred Stock will have
no voting rights prior to that date.
Optional Conversion in the In the event the Series A Preferred Stock has
Event Not Redeemed or not been redeemed or converted on or before
Converted Within 13 October 31, 2000, the Series A Preferred Stock
Months may be converted at the option of the holders
into the Company's Common Stock at the
Conversion Rate.
FIRST AMENDMENT TO PREFERRED STOCK PURCHASE AGREEMENT
This First Amendment to Preferred Stock Purchase Agreement (the
"Amendment") is made and entered into as of the 17th day of March, 2000, by and
among AVIATION GROUP, INC., a Texas corporation (the "Company"), and
XXXXXXXXXX.XXX LTD., an Ontario corporation (the "Investor").
W I T N E S S E T H:
WHEREAS, the Company and the Investor have previously entered into that
certain Preferred Stock Purchase Agreement, dated as of March 1, 2000 (the
"Purchase Agreement"); and
WHEREAS, the Company and the Investor now desire to amend the Purchase
Agreement as set forth below.
NOW THEREFORE, in consideration of the mutual representations,
warranties and covenants herein contained, and on the terms and subject to the
conditions herein set forth, the parties agree as follows:
1. Defined Terms. Unless otherwise defined herein, capitalized
terms used herein shall have the meanings, if any, assigned to them in the
Purchase Agreement.
2. Amendments to the Purchase Agreement.
2
(a) The third and fourth sentences of Section 1.5(a) of the
Purchase Agreement are hereby amended and restated in their entirety to read as
follows:
"Reference is made to that certain amended and restated letter
of intent dated March 16, 2000 from the Investor to the Company (the "Letter of
Intent") for a summary of the intentions of the parties with respect to the
Merger. Subject to and in accordance with the Letter of Intent, the Company and
the Investor agree to negotiate in good faith the terms of the Merger Agreement
and to use reasonable efforts to execute the Merger Agreement as soon as
practicable but in no event later than April 7, 2000."
(b) Section 1.5(b) of the Purchase Agreement is hereby
amended and restated in its entirety to read as follows:
"(b) The consummation of the Merger will be conditioned on (i)
the prior merger of a wholly-owned subsidiary of the Company with and into
Global (the "Global Merger") and (ii) the exchange of the then outstanding
corporate indebtedness and outstanding common stock of Global (the "Debt
Exchange") by the holders thereof for the issuance by the Company to the holders
of such indebtedness and common stock of (a) shares of the Company's Series A
Convertible Preferred Stock (the "Series A Preferred Stock") with an initial
aggregate liquidation preference equal to the principal amount of such
indebtedness (the "Principal Amount") and (b) warrants (the "Exchange Warrants")
to purchase 750,000 shares of the Company's Common Stock. The Exchange Warrants
shall be issued as follows: warrants to purchase 500,000 shares of Company
Common Stock shall be issued to Genesis Diversified Investments, Inc., or its
nominee, and warrants to purchase 250,000 shares of Company Common Stock shall
be issued to Global Leisure, Inc., or its nominee. Pursuant to the terms of the
Global Merger, the Company will issue to the holders of all of Global's
outstanding rights to purchase Global common stock in full cancellation of such
rights, warrants (the "Debt Warrants") to purchase 3.5 million shares of the
Company's Common Stock. The terms of the Debt Warrants and the Exchange Warrants
are set forth in more detail on Exhibit B attached hereto. The terms of the
Series A Preferred Stock are set forth in more detail on Exhibit C attached
hereto. The Company and the Investor agree to cooperate to facilitate the
negotiation, execution and consummation of appropriate merger and exchange
agreements between Global, the Company and the holders of Global's indebtedness
so that the Global Merger and the Debt Exchange can be consummated as soon as
practicable but no later than April 7, 2000."
(c) Section 1.6(a) of the Purchase Agreement is hereby
amended by changing "US$15,000,000" in the first sentence of such section to
"US$20,000,000", and by changing "US$3,000,000" in the first sentence of such
section to "US$2,000,000".
(d) Section 1.6(a) of the Purchase Agreement is hereby
amended by changing "750,000" in the next to last sentence of such section to
"7,500".
(e) Section 3.3(b) of the Purchase Agreement is hereby
amended by changing the number "3,573,929" to "3,849,937".
3
(f) Exhibit A to the Purchase Agreement is hereby amended and
restated in its entirety to read as set forth on Exhibit A attached to this
Amendment.
(g) Exhibit B to the Purchase Agreement is hereby amended and
restated in its entirety to read as set forth on Exhibit B attached to this
Amendment.
(h) Exhibit C to the Purchase Agreement is hereby amended and
restated in its entirety to read as set forth on Exhibit C attached to this
Amendment.
3. Effective Date. This Amendment will become effective upon the
execution hereof by each of the parties set forth on the signature page hereto.
4. Miscellaneous.
(a) Except as expressly amended or waived herein, all terms,
covenants and provisions of the Purchase Agreement shall remain in full force
and effect.
(b) This Amendment shall be binding upon and inure to the
benefit of the parties hereto and the permitted successors, assigns, heirs,
executors and administrators of the parties.
(c) This Amendment shall be governed by and construed under
the laws of the State of Texas without regard to the State's conflict of law
rules.
(d) This Amendment, together with the Purchase Agreement, as
amended, constitutes the full and entire understanding and agreement among the
parties with regard to the subjects hereof and thereof.
(e) This Amendment may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. A telecopy or facsimile
transmission of a signed counterpart of this Amendment shall be sufficient to
bind the party or parties whose signature(s) appear(s) hereon.
[The remainder of this page is intentionally left blank;
signature page follows.]
4
IN WITNESS WHEREOF, the Company and the Investor have executed and
delivered this Amendment as of the day and year first above written.
THE COMPANY:
AVIATION GROUP, INC.
By: /s/ XXXXXXX X. XXXXXX
---------------------
Name: Xxxxxxx X. Xxxxxx
Title: Executive Vice President
INVESTOR:
XXXXXXXXXX.XXX, LTD.
By: /s/ XXXX XXXXX
--------------
Name: Xxxx Xxxxx
Title: Chief Executive Officer
EXHIBIT B
Terms of Warrants
Series The Exchange Warrants, the Debt Warrants and
the Bridge Warrants (together, the "Warrants")
shall be issued in different series. The
Exchange Warrants shall be issued as Series A
Warrants, the Debt Warrants shall be
designated as Series B Warrants, and the
Bridge Warrants shall be designated as Series
C Warrants.
Transferability The Exchange Warrants issued to Global
Leisure, Inc., or its nominee, shall be
non-transferable and non-exercisable until
both of the following conditions are satisfied
within two calendar years of the date of
issuance: (i) the revenues of Global meet or
exceed US$80 million for any one year period
(as defined below), and (ii) Global generates
net income for any one year period (as defined
below). For this purpose, a one year period
shall consist of any four consecutive fiscal
quarters. In addition, until both conditions
are satisfied, the Exchange Warrants shall be
canceled at the option of the Board of
Directors of the Company in the event the
Board determines in good faith that both of
the above conditions will not be met in the
required time period.
Genesis Intermedia shall enter into an
agreement with the Investor and the Company
whereby Genesis Intermedia agrees to provide
exclusive access (other than access provided
to American Express and its affiliates) to its
Centerlinq Network for three years, and
provide such access without charge for the
first year. Such Agreement shall be subject to
the approval of an independent committee of
the board of directors of GenesisIntermedia
which shall occur prior to completion of the
Global Merger. In consideration for entering
into such agreement, (1) the Exchange Warrants
issued to Genesis Diversified Investments,
Inc., or its nominee, shall not be cancelable,
and shall be transferable and exercisable upon
issuance, subject to applicable securities
laws and approval by the Company's
stockholders, and (2) the Company shall redeem
the Series A Preferred Stock issued to Genesis
Diversified Investments, Inc., or its
nominees, (the "Genesis Series A Preferred
Stock") unless previously converted to common
stock, by paying to Genesis Diversified
Investments, Inc., or its nominees, the Series
A Liquidation Preference from the proceeds of
any one or more public financings subsequent
to the completion of the proposed business
combinations and financings contemplated
herein (the "Genesis Series A Redemption") but
only to the extent the proceeds from such
financings exceed the amount necessary to
complete the Series B Redemption, defined
below, and exceed, in the aggregate, US$25
million.
Term Each series shall have a term ending the
earlier of March 5, 2005 or two years from the
date the securities issuable upon their
exercise are freely tradable under the
Securities Act of 1933, as amended, and the
rules and regulations thereunder.
Exercise Price Series A: The Series A Warrants shall have an
exercise price of US$5.00 per share.
Series B: The Series B Warrants shall have an
exercise price of US$3.00 per share.
Series C: The Series C Warrants shall have an
exercise price of US$3.25 per share.
